| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Protein Array Analysis | 10 | 2022 | 503 | 2.530 |
Why?
|
| Proteomics | 17 | 2024 | 1431 | 1.710 |
Why?
|
| Genome, Human | 11 | 2019 | 1853 | 0.990 |
Why?
|
| Genomics | 18 | 2022 | 2845 | 0.940 |
Why?
|
| Metabolic Networks and Pathways | 5 | 2020 | 339 | 0.910 |
Why?
|
| Software | 8 | 2022 | 1342 | 0.790 |
Why?
|
| Mutation Rate | 3 | 2018 | 227 | 0.790 |
Why?
|
| Proteins | 2 | 2022 | 1976 | 0.770 |
Why?
|
| Biochemical Phenomena | 1 | 2020 | 5 | 0.720 |
Why?
|
| Neoplasms | 23 | 2024 | 15797 | 0.720 |
Why?
|
| Mutation | 29 | 2024 | 15640 | 0.680 |
Why?
|
| Gene Expression Regulation, Neoplastic | 19 | 2024 | 9065 | 0.620 |
Why?
|
| Transforming Growth Factor beta | 3 | 2018 | 1151 | 0.610 |
Why?
|
| DNA Methylation | 17 | 2019 | 2729 | 0.570 |
Why?
|
| Quality Control | 5 | 2022 | 459 | 0.490 |
Why?
|
| Signal Transduction | 16 | 2018 | 12145 | 0.470 |
Why?
|
| Neoplasm Proteins | 8 | 2019 | 3276 | 0.460 |
Why?
|
| Drug Discovery | 1 | 2016 | 334 | 0.440 |
Why?
|
| Immunoassay | 1 | 2014 | 221 | 0.440 |
Why?
|
| Genome | 3 | 2020 | 678 | 0.430 |
Why?
|
| MicroRNAs | 15 | 2019 | 2961 | 0.420 |
Why?
|
| Carcinoma, Renal Cell | 4 | 2023 | 2404 | 0.400 |
Why?
|
| Proteome | 4 | 2019 | 577 | 0.390 |
Why?
|
| Biomarkers, Tumor | 10 | 2024 | 10641 | 0.370 |
Why?
|
| Chromatin | 5 | 2024 | 971 | 0.360 |
Why?
|
| Gene Expression Profiling | 12 | 2019 | 5228 | 0.340 |
Why?
|
| Phosphatidylinositol 3-Kinases | 6 | 2017 | 1710 | 0.340 |
Why?
|
| Protein Interaction Maps | 2 | 2020 | 150 | 0.320 |
Why?
|
| Colonic Neoplasms | 2 | 2016 | 1424 | 0.310 |
Why?
|
| DNA Copy Number Variations | 8 | 2024 | 1540 | 0.300 |
Why?
|
| Urinary Bladder Neoplasms | 3 | 2017 | 2429 | 0.300 |
Why?
|
| Cluster Analysis | 8 | 2018 | 1081 | 0.300 |
Why?
|
| Gene Dosage | 4 | 2014 | 834 | 0.290 |
Why?
|
| Databases, Nucleic Acid | 2 | 2019 | 115 | 0.290 |
Why?
|
| RNA, Messenger | 10 | 2018 | 6221 | 0.280 |
Why?
|
| Lung Neoplasms | 6 | 2018 | 11638 | 0.280 |
Why?
|
| Proteogenomics | 2 | 2018 | 110 | 0.280 |
Why?
|
| Humans | 64 | 2024 | 270969 | 0.270 |
Why?
|
| Computational Biology | 5 | 2020 | 1281 | 0.260 |
Why?
|
| Proto-Oncogene Proteins c-akt | 5 | 2017 | 2081 | 0.260 |
Why?
|
| Kidney Neoplasms | 4 | 2023 | 3116 | 0.240 |
Why?
|
| Adenocarcinoma | 4 | 2018 | 7877 | 0.240 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2018 | 5495 | 0.230 |
Why?
|
| Rectal Neoplasms | 1 | 2012 | 1241 | 0.230 |
Why?
|
| Ovarian Neoplasms | 4 | 2014 | 4720 | 0.210 |
Why?
|
| TOR Serine-Threonine Kinases | 4 | 2017 | 1559 | 0.200 |
Why?
|
| Neoplasms, Glandular and Epithelial | 2 | 2018 | 520 | 0.190 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2023 | 228 | 0.190 |
Why?
|
| Transcriptome | 5 | 2018 | 1963 | 0.190 |
Why?
|
| Antineoplastic Agents | 4 | 2020 | 14558 | 0.180 |
Why?
|
| DNA Polymerase II | 2 | 2018 | 60 | 0.180 |
Why?
|
| Loss of Heterozygosity | 2 | 2019 | 622 | 0.180 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 540 | 0.180 |
Why?
|
| Poly-ADP-Ribose Binding Proteins | 2 | 2018 | 110 | 0.180 |
Why?
|
| Computers | 1 | 2020 | 141 | 0.170 |
Why?
|
| Carcinoma | 1 | 2011 | 2602 | 0.170 |
Why?
|
| Genes, p53 | 2 | 2015 | 1110 | 0.170 |
Why?
|
| Bone Morphogenetic Protein 5 | 1 | 2018 | 9 | 0.160 |
Why?
|
| Gene Regulatory Networks | 3 | 2018 | 677 | 0.160 |
Why?
|
| DNA Mutational Analysis | 3 | 2013 | 2298 | 0.160 |
Why?
|
| Transcription Factors, TFII | 1 | 2018 | 23 | 0.160 |
Why?
|
| Smad Proteins | 1 | 2018 | 92 | 0.150 |
Why?
|
| RNA, Neoplasm | 3 | 2019 | 796 | 0.150 |
Why?
|
| MutL Protein Homolog 1 | 1 | 2018 | 200 | 0.150 |
Why?
|
| Cell Line, Tumor | 7 | 2024 | 14928 | 0.150 |
Why?
|
| Recombinational DNA Repair | 1 | 2018 | 81 | 0.150 |
Why?
|
| Cancer Vaccines | 1 | 2023 | 733 | 0.150 |
Why?
|
| Molecular Targeted Therapy | 4 | 2020 | 2388 | 0.150 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2022 | 2160 | 0.140 |
Why?
|
| Chromosomal Instability | 1 | 2018 | 232 | 0.140 |
Why?
|
| Organ Specificity | 2 | 2018 | 698 | 0.140 |
Why?
|
| Internet | 2 | 2017 | 741 | 0.130 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2016 | 229 | 0.130 |
Why?
|
| Carcinosarcoma | 1 | 2017 | 146 | 0.130 |
Why?
|
| Isocitrate Dehydrogenase | 2 | 2017 | 522 | 0.130 |
Why?
|
| Uveal Neoplasms | 1 | 2017 | 190 | 0.130 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2018 | 349 | 0.120 |
Why?
|
| Reproducibility of Results | 2 | 2022 | 6181 | 0.120 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 1663 | 0.120 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2018 | 464 | 0.120 |
Why?
|
| Molecular Typing | 1 | 2014 | 55 | 0.120 |
Why?
|
| Thymoma | 1 | 2018 | 251 | 0.120 |
Why?
|
| Liver Neoplasms | 3 | 2022 | 4793 | 0.120 |
Why?
|
| Glioma | 2 | 2016 | 2001 | 0.120 |
Why?
|
| Databases, Genetic | 4 | 2018 | 751 | 0.120 |
Why?
|
| Testicular Neoplasms | 1 | 2018 | 552 | 0.120 |
Why?
|
| Pleural Neoplasms | 1 | 2018 | 479 | 0.110 |
Why?
|
| Virus Integration | 1 | 2014 | 73 | 0.110 |
Why?
|
| GRB10 Adaptor Protein | 1 | 2013 | 19 | 0.110 |
Why?
|
| Atlases as Topic | 1 | 2013 | 45 | 0.110 |
Why?
|
| Education | 1 | 2014 | 123 | 0.110 |
Why?
|
| Adrenocortical Carcinoma | 1 | 2016 | 190 | 0.110 |
Why?
|
| Information Dissemination | 1 | 2016 | 275 | 0.110 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2015 | 261 | 0.110 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2013 | 55 | 0.110 |
Why?
|
| Mesothelioma | 1 | 2018 | 554 | 0.110 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2014 | 165 | 0.110 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2013 | 71 | 0.110 |
Why?
|
| Adrenal Cortex Neoplasms | 1 | 2016 | 242 | 0.110 |
Why?
|
| Citric Acid Cycle | 1 | 2013 | 93 | 0.110 |
Why?
|
| Melanoma | 2 | 2022 | 5393 | 0.110 |
Why?
|
| Epigenesis, Genetic | 3 | 2018 | 1446 | 0.110 |
Why?
|
| Thymus Neoplasms | 1 | 2018 | 414 | 0.110 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2018 | 622 | 0.100 |
Why?
|
| Ubiquitin Thiolesterase | 3 | 2018 | 224 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2015 | 424 | 0.100 |
Why?
|
| Alternative Splicing | 1 | 2015 | 599 | 0.100 |
Why?
|
| Genes, p16 | 1 | 2012 | 131 | 0.100 |
Why?
|
| Uterine Neoplasms | 1 | 2017 | 567 | 0.100 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2018 | 1000 | 0.100 |
Why?
|
| Colon | 1 | 2016 | 678 | 0.100 |
Why?
|
| Bile Duct Neoplasms | 1 | 2017 | 498 | 0.100 |
Why?
|
| Statistics, Nonparametric | 1 | 2014 | 990 | 0.100 |
Why?
|
| Cholangiocarcinoma | 1 | 2017 | 501 | 0.100 |
Why?
|
| Survival Analysis | 4 | 2018 | 9311 | 0.100 |
Why?
|
| Carcinoma, Papillary | 1 | 2015 | 590 | 0.100 |
Why?
|
| Carcinogenesis | 1 | 2018 | 1040 | 0.100 |
Why?
|
| Female | 20 | 2023 | 147624 | 0.100 |
Why?
|
| Breast Neoplasms | 6 | 2024 | 16073 | 0.100 |
Why?
|
| Sequence Analysis, DNA | 3 | 2015 | 2496 | 0.090 |
Why?
|
| Oncogenes | 1 | 2014 | 674 | 0.090 |
Why?
|
| Adenoma | 1 | 2016 | 736 | 0.090 |
Why?
|
| Models, Biological | 3 | 2018 | 3242 | 0.090 |
Why?
|
| Genital Neoplasms, Female | 1 | 2018 | 784 | 0.090 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2013 | 296 | 0.090 |
Why?
|
| Bayes Theorem | 3 | 2020 | 1050 | 0.090 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2013 | 407 | 0.090 |
Why?
|
| Algorithms | 3 | 2018 | 3980 | 0.090 |
Why?
|
| Exome | 2 | 2013 | 1263 | 0.090 |
Why?
|
| Tumor Suppressor Proteins | 4 | 2018 | 1872 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2014 | 802 | 0.090 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2014 | 1269 | 0.090 |
Why?
|
| DNA, Neoplasm | 1 | 2015 | 1916 | 0.080 |
Why?
|
| Protein Kinases | 1 | 2014 | 888 | 0.080 |
Why?
|
| Neovascularization, Pathologic | 2 | 2014 | 1583 | 0.080 |
Why?
|
| CpG Islands | 3 | 2018 | 642 | 0.080 |
Why?
|
| Sex Factors | 1 | 2014 | 2198 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2018 | 4329 | 0.080 |
Why?
|
| Indoles | 1 | 2014 | 1028 | 0.080 |
Why?
|
| Down-Regulation | 1 | 2014 | 2110 | 0.080 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2019 | 1906 | 0.080 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2019 | 2348 | 0.080 |
Why?
|
| Cell Cycle | 1 | 2014 | 2109 | 0.080 |
Why?
|
| Datasets as Topic | 2 | 2019 | 176 | 0.080 |
Why?
|
| RNA, Long Noncoding | 3 | 2018 | 621 | 0.070 |
Why?
|
| Epithelial-Mesenchymal Transition | 3 | 2018 | 992 | 0.070 |
Why?
|
| Gene Deletion | 1 | 2012 | 1472 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2014 | 1166 | 0.070 |
Why?
|
| Middle Aged | 12 | 2019 | 89661 | 0.070 |
Why?
|
| Biomarkers | 1 | 2019 | 5161 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2019 | 3621 | 0.070 |
Why?
|
| DNA-Binding Proteins | 5 | 2018 | 4893 | 0.070 |
Why?
|
| Aneuploidy | 2 | 2018 | 373 | 0.070 |
Why?
|
| Microsatellite Instability | 2 | 2018 | 418 | 0.070 |
Why?
|
| Nuclear Proteins | 4 | 2018 | 3362 | 0.060 |
Why?
|
| Cell Cycle Proteins | 1 | 2014 | 2093 | 0.060 |
Why?
|
| Aged | 9 | 2018 | 73018 | 0.060 |
Why?
|
| Sulfonamides | 1 | 2014 | 1900 | 0.060 |
Why?
|
| Male | 11 | 2022 | 127769 | 0.060 |
Why?
|
| Receptor, ErbB-2 | 1 | 2014 | 2629 | 0.060 |
Why?
|
| Cell Proliferation | 4 | 2020 | 7333 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2019 | 6269 | 0.060 |
Why?
|
| Genes, MHC Class I | 1 | 2023 | 46 | 0.060 |
Why?
|
| Endometrial Neoplasms | 1 | 2013 | 1360 | 0.060 |
Why?
|
| Nucleotidyltransferases | 1 | 2023 | 89 | 0.060 |
Why?
|
| Phenotype | 3 | 2022 | 6353 | 0.050 |
Why?
|
| DNA Damage | 2 | 2023 | 1983 | 0.050 |
Why?
|
| ErbB Receptors | 2 | 2024 | 2337 | 0.050 |
Why?
|
| Cell Movement | 3 | 2016 | 2510 | 0.050 |
Why?
|
| Transcription Factors | 4 | 2018 | 5360 | 0.050 |
Why?
|
| Ecosystem | 1 | 2022 | 111 | 0.050 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2023 | 436 | 0.050 |
Why?
|
| Tumor Microenvironment | 2 | 2023 | 3002 | 0.040 |
Why?
|
| Controlled Before-After Studies | 1 | 2019 | 2 | 0.040 |
Why?
|
| Health Information Exchange | 1 | 2019 | 15 | 0.040 |
Why?
|
| Prognosis | 4 | 2018 | 22348 | 0.040 |
Why?
|
| Adult | 8 | 2019 | 80872 | 0.040 |
Why?
|
| Immunotherapy | 2 | 2023 | 3518 | 0.040 |
Why?
|
| Sample Size | 1 | 2020 | 205 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 2 | 2017 | 3098 | 0.040 |
Why?
|
| Neoplasm Grading | 2 | 2015 | 1806 | 0.040 |
Why?
|
| Clinical Studies as Topic | 1 | 2019 | 19 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2016 | 5458 | 0.040 |
Why?
|
| Protein Methyltransferases | 1 | 2018 | 44 | 0.040 |
Why?
|
| User-Computer Interface | 1 | 2020 | 290 | 0.040 |
Why?
|
| Molecular Sequence Annotation | 1 | 2019 | 196 | 0.040 |
Why?
|
| Brain Neoplasms | 1 | 2016 | 5019 | 0.040 |
Why?
|
| Antibodies, Neoplasm | 1 | 2019 | 264 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2014 | 4921 | 0.040 |
Why?
|
| beta Catenin | 1 | 2022 | 696 | 0.040 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2018 | 52 | 0.040 |
Why?
|
| Eukaryotic Initiation Factor-1 | 1 | 2017 | 15 | 0.040 |
Why?
|
| Seminoma | 1 | 2018 | 89 | 0.040 |
Why?
|
| Serine-Arginine Splicing Factors | 1 | 2017 | 88 | 0.040 |
Why?
|
| Monosomy | 1 | 2017 | 96 | 0.040 |
Why?
|
| Consensus | 1 | 2022 | 1104 | 0.040 |
Why?
|
| Chromosomes | 1 | 2018 | 251 | 0.040 |
Why?
|
| RNA Splicing | 1 | 2019 | 377 | 0.040 |
Why?
|
| SOX9 Transcription Factor | 1 | 2018 | 176 | 0.030 |
Why?
|
| Muscle, Smooth | 1 | 2017 | 244 | 0.030 |
Why?
|
| RNA Splicing Factors | 1 | 2017 | 153 | 0.030 |
Why?
|
| Breast | 1 | 2023 | 1361 | 0.030 |
Why?
|
| Workflow | 1 | 2018 | 290 | 0.030 |
Why?
|
| Genes, Neoplasm | 1 | 2018 | 325 | 0.030 |
Why?
|
| Gene Editing | 1 | 2019 | 231 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2018 | 490 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2020 | 5298 | 0.030 |
Why?
|
| X-linked Nuclear Protein | 1 | 2016 | 59 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2018 | 490 | 0.030 |
Why?
|
| B7-H1 Antigen | 1 | 2022 | 1061 | 0.030 |
Why?
|
| DNA | 1 | 2023 | 2733 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2018 | 838 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2015 | 142 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2016 | 590 | 0.030 |
Why?
|
| Machine Learning | 1 | 2018 | 365 | 0.030 |
Why?
|
| Urinary Bladder | 1 | 2017 | 583 | 0.030 |
Why?
|
| Animals | 4 | 2023 | 61175 | 0.030 |
Why?
|
| Cell Survival | 1 | 2020 | 3064 | 0.030 |
Why?
|
| ras Proteins | 1 | 2018 | 784 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2015 | 324 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2016 | 254 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2016 | 1182 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2016 | 656 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2018 | 5431 | 0.030 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2013 | 7130 | 0.030 |
Why?
|
| DNA Helicases | 1 | 2016 | 449 | 0.030 |
Why?
|
| Neoplasm Metastasis | 2 | 2014 | 5250 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 30845 | 0.030 |
Why?
|
| Tyrosine | 1 | 2014 | 508 | 0.030 |
Why?
|
| Disease-Free Survival | 2 | 2016 | 10092 | 0.030 |
Why?
|
| Telomerase | 1 | 2016 | 535 | 0.030 |
Why?
|
| RNA | 1 | 2017 | 1024 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2018 | 1425 | 0.030 |
Why?
|
| Telomere | 1 | 2016 | 517 | 0.030 |
Why?
|
| Cell Line | 1 | 2020 | 5122 | 0.030 |
Why?
|
| Pericytes | 1 | 2013 | 97 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2018 | 1008 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2015 | 688 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 2013 | 232 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2017 | 1175 | 0.020 |
Why?
|
| Gene Fusion | 1 | 2013 | 214 | 0.020 |
Why?
|
| Histones | 1 | 2019 | 1493 | 0.020 |
Why?
|
| Epigenomics | 1 | 2013 | 270 | 0.020 |
Why?
|
| Adolescent | 3 | 2018 | 32464 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2018 | 1379 | 0.020 |
Why?
|
| Survival Rate | 2 | 2016 | 12475 | 0.020 |
Why?
|
| BRCA2 Protein | 1 | 2012 | 366 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2018 | 2314 | 0.020 |
Why?
|
| Precision Medicine | 1 | 2018 | 1213 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2013 | 528 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2018 | 2131 | 0.020 |
Why?
|
| DNA Repair | 1 | 2018 | 1879 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2016 | 3594 | 0.020 |
Why?
|
| Mitochondria | 1 | 2017 | 1315 | 0.020 |
Why?
|
| BRCA1 Protein | 1 | 2012 | 512 | 0.020 |
Why?
|
| Antigens, Neoplasm | 1 | 2016 | 1561 | 0.020 |
Why?
|
| Young Adult | 2 | 2018 | 22268 | 0.020 |
Why?
|
| Nanoparticles | 1 | 2013 | 584 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2014 | 1078 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2017 | 6034 | 0.020 |
Why?
|
| Recurrence | 1 | 2016 | 4889 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2016 | 5677 | 0.020 |
Why?
|
| Liver | 1 | 2017 | 2993 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2014 | 4341 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 5094 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2014 | 4887 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 2013 | 1977 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 7711 | 0.020 |
Why?
|
| Gene Expression | 1 | 2013 | 3574 | 0.020 |
Why?
|
| Disease Progression | 1 | 2016 | 6881 | 0.010 |
Why?
|
| Glioblastoma | 1 | 2015 | 1845 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 5015 | 0.010 |
Why?
|
| Risk Factors | 1 | 2019 | 18036 | 0.010 |
Why?
|
| Apoptosis | 1 | 2016 | 7756 | 0.010 |
Why?
|
| Mice | 1 | 2022 | 35455 | 0.010 |
Why?
|
| Pancreatic Neoplasms | 1 | 2017 | 5231 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2012 | 13336 | 0.010 |
Why?
|
| Child | 1 | 2016 | 30357 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2013 | 34335 | 0.010 |
Why?
|